Buy Crypto Markets Spot FuturesZEC Earn Event Centre Rewards Hub

vTv Therapeutics Inc. (VTVT)

NASDAQ

$32.93

$-0.42

(-1.27%)

Previous Close: ⁦$0.00⁩

Market Closed

vTv Therapeutics Inc. (VTVT) Live Price Chart

Last updated: ⁦2026-09-09 05:06:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

vTv Therapeutics Inc. (VTVT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $32.93, with a market capitalisation of $131.86M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $18.76 to $44.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$131.86M
Open	$33.35
Day's High	$560.00
Day's Low	$7.38
Previous Close	--
Volume	27.50K
Average Volume	74.61K
P/E Ratio	--
52-Week High	$44.00
52-Week Low	$18.76
Dividend Yield	--
Earnings Date	--

vTv Therapeutics Inc. (VTVT) Latest Closing Stock Price

vTv Therapeutics Inc. (VTVT) last closed at $0.00 as of 2026-09-08 23:31:00, -- from the previous close of $0.00.

During the latest regular trading session, VTVT traded between $7.38 and $560.00, with a volume of 27.50K shares. The closing price was near the lower end and near the middle of its 52-week range.

vTv Therapeutics Inc. (VTVT) 7-Day Stock Price Change

Over the past seven days, vTv Therapeutics Inc. (VTVT) moved from $32.80 to $32.93, representing a gain of 0.39% ($0.13).

The stock traded between $31.35 and $34.09 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 52.60 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

VTVT 52-Week Price Position

Position in Range: 56.1%

52W Low$18.76

52W High$44.00

VTVT is currently trading at $32.93, placing it 56.1% of the way from its 52-week low of $18.76 to its 52-week high of $44.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is vTv Therapeutics Inc. (VTVT)?

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

vTv Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	26
Exchange	NASDAQ
Company Website	https://www.vtvtherapeutics.com

How to Buy vTv Therapeutics Inc. (VTVT) Stock on MEXC

Eligible investors can buy real shares of vTv Therapeutics Inc. (VTVT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VTVT and Place Your Order

Open the RealStocks trading page and search for VTVT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is vTv Therapeutics Inc. (VTVT) share price today?

vTv Therapeutics Inc. (VTVT) is currently trading at $ 32.93, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is VTVT stock going up or down today?

As of 2026-09-08 23:31:00, VTVT is trading at $ 32.93, -- from its previous close of --. The stock has traded between $ 7.38 and $ 560.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is VTVT pre-market price?

As of 2026-09-08 23:31:00, VTVT is trading at $ 33.35 in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VTVT after-hours price?

As of 2026-09-08 23:31:00, VTVT is trading at $ 32.86 in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is VTVT stock trading now?

VTVT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VTVT sit relative to its 52-week high and low?

Over the past 52 weeks, VTVT has traded between a low of $ 18.76 and a high of $ 44.00. At $ 32.93, the stock is positioned 56.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is vTv Therapeutics Inc. in?

vTv Therapeutics Inc. (VTVT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is vTv Therapeutics Inc.'s market capitalisation and where is it listed?

vTv Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 131.86M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VTVT valued in terms of P/E ratio and EPS?

VTVT trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does vTv Therapeutics Inc. pay a dividend?

vTv Therapeutics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.